Part one was the graveyard. Eight hundred and one tickers I looked at and passed on, published free, because I think the volume of no is the most underrated thing in this business and nobody shows it to you.
This is the other half.
One hundred and seven names cleared. Some I own. Some I want and refuse to pay up for. I’m not going to tell you which is which, and I’d encourage you to stop caring, because the useful information isn’t my cost basis. It’s the level. What the business is, why it might work, whether the people running it are buying their own stock, and the price at which I’d be willing to be wrong.
That last part is where most research quietly cheats. Everybody has a thesis. Almost nobody publishes the number where the thesis becomes a position, because publishing the number means you can be measured against it later.
So here’s every number.
Fair warning on what this is not. It isn’t a portfolio. If you bought all 107 you’d own a slightly worse index fund with more paperwork. It isn’t a set of recommendations sized for your situation, which I know nothing about. Several of these are outright lottery tickets and I’ve said so where that’s true. A few of them will be down eighty percent by next summer and the ones that get me will not be the ones I flagged as risky.
What it is: the full working list, organized the way I actually think about it, with the insider data pulled from filings rather than from somebody’s summary of filings. Where an insider bought, I name them and the price they paid. Where they only sold, I say that too, because a stock I like where the CEO is dumping is a stock I like with an asterisk, and the asterisk belongs in print.
One more thing before the list, and I mean this literally rather than as a bit.
I probably shouldn’t be publishing this. Several of these are names I intend to buy in the next regular hours session. Not eventually, not if conditions develop. Next session. Which means I am handing you a list of levels that I am about to go compete with you for.
Have fun front running me.
I’m doing it anyway because the alternative is publishing after I’ve filled, which is the version of this business I find genuinely gross. Telling you what I bought is marketing. Telling you what I’m about to buy costs me something. If a few of you get better fills than I do on Monday, that’s the price of running this the way I said I’d run it, and I’d rather pay it than write the other kind of newsletter.
Also join the chat for live ideas and a great community of like minded and diverse PMs and traders.
Read the levels. Ignore the noise. And if you disagree with one, that’s the point.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.